Omnitrope and Tremor - a phase IV clinical study of FDA data

Summary:

Tremor is reported as a side effect among people who take Omnitrope (somatropin recombinant), especially for people who are female, 2-9 old, have been taking the drug for < 1 month also take Singulair, and have Hypothalamo-pituitary disorder.

The phase IV clinical study analyzes which people have Tremor when taking Omnitrope. It is created by eHealthMe based on reports of 8,562 people who have side effects when taking Omnitrope from the FDA, and is updated regularly.

What is Omnitrope?

Omnitrope has active ingredients of somatropin recombinant. It is often used in growth hormone deficiency. eHealthMe is studying from 8,582 Omnitrope users. Check the latest studies of Omnitrope.

What is Tremor?

Tremor (trembling or shaking movements in one or more parts of your body) is found to be associated with 2,644 drugs and 3,728 conditions by eHealthMe. Check the latest studies of Tremor.

On Jul, 19, 2026

8,562 people reported to have side effects when taking Omnitrope.
Among them, 49 people (0.57%) have Tremor.

Among these 49 people:

How long have people been on Omnitrope when they have Tremor? *

What is the gender of people who have Tremor when taking Omnitrope? *

female: 65.31 %
male: 34.69 %

What is the age of people who have Tremor when taking Omnitrope? *

What are other drugs people take besides Omnitrope? *

What are other side effects people have besides Tremor? *

Injection Site Pain: 11 people, 22.45%
Malaise (a feeling of general discomfort or uneasiness): 10 people, 20.41%
Headache (pain in head): 9 people, 18.37%
Urinary Incontinence (inability to control the flow of urine and involuntary urination): 8 people, 16.33%
Feeling Abnormal: 8 people, 16.33%
Injection Site Swelling: 7 people, 14.29%
Failure To Thrive (inadequate weight gain and physical growth in children): 7 people, 14.29%
Injection Site Bruising: 7 people, 14.29%
Reading Disorder (problem in areas of the brain that help interpret language): 7 people, 14.29%
Chest Pain: 6 people, 12.24%

What are the existing conditions these people have? *

Hypothalamo-Pituitary Disorder (loss of function in an endocrine gland due to failure of the pituitary gland to secrete hormones which stimulate that gland's function): 3 people, 6.12%
Hypopituitarism (diminished hormone secretion by the pituitary gland, causing dwarfism in children and premature aging in adults): 2 people, 4.08%
Hypersensitivity: 2 people, 4.08%
Hyperpituitarism (excessive activity of the pituitary gland): 2 people, 4.08%
Asthma: 2 people, 4.08%
Rickets (softening of bones): 1 person, 2.04%
Polycystic Ovary Disease (cysts in the ovaries that occurs when the follicle stops developing): 1 person, 2.04%
Immune System Disorder: 1 person, 2.04%
High Blood Pressure: 1 person, 2.04%
Hair Loss: 1 person, 2.04%

* Approximation only. Some reports may have incomplete information.

Do you take Omnitrope and have Tremor?

- Check whether Tremor is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Omnitrope:

Omnitrope (8,582 reports)

Tremor treatments and more:

Tremor (195,267 reports)

Browse all side effects of Omnitrope:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Tremor:

Tremor (2,644 drugs)

Browse all the conditions that are associated with Tremor:

Tremor (3,728 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on somatropin recombinant (the active ingredients of Omnitrope) and Omnitrope (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.